These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12147333)

  • 21. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Angiotensin-converting enzyme insertion(I)/deletion (D) genotype in Alzheimer's disease patients of north Indian population.
    Nirmal S; Tripathi M; Shastri SS; Sagar R; S V
    Int J Neurosci; 2011 Oct; 121(10):557-61. PubMed ID: 21770707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between ACE polymorphism, cognitive phenotype and APOE E4 allele in a Tunisian population with Alzheimer disease.
    Achouri-Rassas A; Ali NB; Cherif A; Fray S; Siala H; Zakraoui NO; Hadj-Fredj S; Kechaou M; Anane N; Echebi S; Messaoud T; Belal S
    J Neural Transm (Vienna); 2016 Mar; 123(3):317-21. PubMed ID: 26456241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between angiotensin-converting enzyme gene and late onset Alzheimer's disease in Han chinese.
    Yang JD; Feng G; Zhang J; Lin ZX; Shen T; Breen G; St Clair D; He L
    Neurosci Lett; 2000 Dec; 295(1-2):41-4. PubMed ID: 11078932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The insertion polymorphism in angiotensin-converting enzyme gene associated with the APOE epsilon 4 allele increases the risk of late-onset Alzheimer disease.
    Wang B; Jin F; Yang Z; Lu Z; Kan R; Li S; Zheng C; Wang L
    J Mol Neurosci; 2006; 30(3):267-71. PubMed ID: 17401152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
    Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.
    Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K
    J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the association between Alzheimer's disease and angiotensin-converting enzyme gene polymorphism using DNA from lymphocytes.
    Cheng CY; Hong CJ; Liu HC; Liu TY; Tsai SJ
    Eur Neurol; 2002; 47(1):26-9. PubMed ID: 11803189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset.
    Chen L; Baum L; Ng HK; Chan LY; Pang CP
    Hum Pathol; 1999 Oct; 30(10):1172-7. PubMed ID: 10534164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.
    Mann DM; Pickering-Brown SM; Takeuchi A; Iwatsubo T;
    Am J Pathol; 2001 Jun; 158(6):2165-75. PubMed ID: 11395394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease.
    Mandler M; Walker L; Santic R; Hanson P; Upadhaya AR; Colloby SJ; Morris CM; Thal DR; Thomas AJ; Schneeberger A; Attems J
    Acta Neuropathol; 2014 Jul; 128(1):67-79. PubMed ID: 24861310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ACE gene and Alzheimer's disease susceptibility.
    Narain Y; Yip A; Murphy T; Brayne C; Easton D; Evans JG; Xuereb J; Cairns N; Esiri MM; Furlong RA; Rubinsztein DC
    J Med Genet; 2000 Sep; 37(9):695-7. PubMed ID: 10978362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease.
    Rocha NP; Toledo A; Corgosinho LTS; de Souza LC; Guimarães HC; Resende EPF; Braz NFT; Gomes KB; Simoes E Silva AC; Caramelli P; Teixeira AL
    J Alzheimers Dis; 2018; 64(4):1085-1090. PubMed ID: 30040721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
    Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y
    Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease.
    Ingelsson M; Jesneck J; Irizarry MC; Hyman BT; Rebeck GW
    Neurosci Lett; 2004 Sep; 367(2):228-31. PubMed ID: 15331159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
    Chalmers KA; Culpan D; Kehoe PG; Wilcock GK; Hughes A; Love S
    Neuroreport; 2004 Jan; 15(1):95-8. PubMed ID: 15106838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease.
    Popp J; Lewczuk P; Linnebank M; Cvetanovska G; Smulders Y; Kölsch H; Frommann I; Kornhuber J; Maier W; Jessen F
    J Alzheimers Dis; 2009; 18(4):819-28. PubMed ID: 19661622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.